Electrochemotherapy under tumescent local anesthesia for the treatment of cutaneous metastases

Dermatologic Surgery

Volumn 39, Issue 7, 2013, Pages 1023-1032

  Kendler, Michael ^a   Micheluzzi, Martin ^a   Wetzig, Tino ^a   Simon, Jan C ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CEFUROXIME; DIPYRONE; LIDOCAINE; ROPIVACAINE;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; BREAST; BREAST CANCER; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER REGRESSION; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CUTANEOUS MELANOMA; ELECTROCHEMOTHERAPY; FEMALE; GENERAL ANESTHESIA; HUMAN; KARNOFSKY PERFORMANCE STATUS; LOCAL ANESTHESIA; MALE; MELANOMA; METASTASIS RESECTION; MUSCLE CONTRACTION; NEOPLASM; PAIN ASSESSMENT; PILOT STUDY; PRIORITY JOURNAL; QUALITY OF LIFE; SKIN INFECTION; SKIN METASTASIS; SUBCUTANEOUS TISSUE; TREATMENT RESPONSE; ULCER; VISUAL ANALOG SCALE;

AGED; AGED, 80 AND OVER; ANESTHESIA, LOCAL; ANTIBIOTICS, ANTINEOPLASTIC; BLEOMYCIN; ELECTROCHEMOTHERAPY; FEMALE; HUMANS; LYMPHOMA, B-CELL; MALE; PAIN MEASUREMENT; PALLIATIVE CARE; PILOT PROJECTS; PROSPECTIVE STUDIES; QUALITY OF LIFE; SKIN NEOPLASMS;

EID: 84879884119     PISSN: 10760512     EISSN: 15244725     Source Type: Journal    
DOI: 10.1111/dsu.12190     Document Type: Article

References (32)

1. Rolz-Cruz G, Kim CC,. Tumor invasion of the skin. Dermatol Clin 2008; 26: 89-102.
2. Matthiessen LW, Chalmers RL, Sainsbury DC, Veeramani S, et al. Management of cutaneous metastases using electrochemotherapy. Acta Oncol 2011; 50: 621-9.
3. Heller R, Jaroszeski MJ, Reintgen DS, Puleo CA, et al. Treatment of cutaneous and subcutaneous tumors with electrochemotherapy using intralesional bleomycin. Cancer 1998; 83: 148-57.
4. Gehl J, Geertsen PF,. Efficient palliation of haemorrhaging malignant melanoma skin metastases by electrochemotherapy. Melanoma Res 2000; 10: 585-9.
5. Mir LM, Gehl J, Sersa G, Collins CG, et al. Standard operating procedures of the electrochemotherapy: instructions for the use of bleomycin or cisplatin administered either systemically or locally and electric pulses delivered by the Cliniporator™ by means of invasive or non-invasive elctrodes. Eur J Cancer Suppl 2006; 4: 14-25.
6. Kis E, Oláh J, Ócsai H, Baltas E, et al. Electrochemotherapy of cutaneous metastases of melanoma-a case series study and systematic review of the evidence. Dermatol Surg 2011; 37: 816-24.
7. Wetzig T, Averbeck M, Simon JC, Kendler M,. Local anesthesia in dermatology. J Dtsch Dermatol Ges 2010; 8: 1007-17.
8. Price DD, Bush FM, Long S, Harkins SW,. A comparison of pain measurement characteristics of mechanical visual analogue and simple numerical rating scales. Pain 1994; 56: 217-26.
9. Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 2009; 45: 228-47.
10. Stoffels I, Dissemond J, Schulz A, Hillen U, et al. Reliability and cost-effectiveness of complete lymph node dissection under tumescent local anaesthesia vs. general anaesthesia: a retrospective analysis in patients with malignant melanoma AJCC stage III. J Eur Acad Dermatol Venereol 2012; 26: 200-6.
11. Habbema L,. Efficacy of tumescent local anesthesia with variable lidocaine concentration in 3430 consecutive cases of liposuction. J Am Acad Dermatol 2010; 62: 988-94.
12. Rudlof K, Rüffert H, Wehner M, Wetzig T, et al. Tumescent anaesthesia for dermatological surgery. Plasma concentrations of lidocaine and prilocaine. Anaesthesist 2007; 56: 785-9.
13. Wall ML, Dealey C, Davies RS, Simms MH,. Local versus general anaesthesia for varicose veins surgery: a prospective non-randomized controlled trial. Phlebology 2009; 24: 61-6.
14. Landström FJ, Nilsson CO, Crafoord S, Reizenstein JA, et al. Electroporation therapy of skin cancer in the head and neck area. Dermatol Surg 2010; 36: 1245-50.
15. Dillane D, Finucane BT,. Local anesthetic systemic toxicity. Can J Anaesth 2010; 57: 368-80.
16. Klein JA,. The tumescent technique for liposuction surgery. Am J Cosmet Surg 1987; 4: 263-7.
17. Hanke W, Cox SE, Kuznets N, Coleman WP 3rd,. Tumescent liposuction report performance measurement initiative: national survey results. Dermatol Surg 2004; 30: 967-77.
18. Breuninger H, Hobbach PS, Schimek F,. Ropivacaine: an important anesthetic agent for slow infusion and other forms of tumescent anesthesia. Dermatol Surg 1999; 25: 799-802.
19. Rubin JP, Bierman C, Rosow CE, Arthur GR, et al. The tumescent technique: the effect of high tissue pressure and dilute epinephrine on absorption of lidocaine. Plast Reconstr Surg 1999; 103: 990-6.
20. Häfner HM, Schmid U, Moehrle M, Strölin A, et al. Changes in acral blood flux under local application of ropivacaine and lidocaine with and without an adrenaline additive: a double-blind, randomized, placebo-controlled study. Clin Hemorheol Microcirc 2008; 38: 279-88.
21. Butterworth JF 4th, Strichartz GR,. Molecular mechanisms of local anesthesia: a review. Anesthesiology 1990; 72: 711-34.
22. Pron G, Belehradek J Jr, Mir LM,. Identification of a plasma membrane proteinthat specifically binds bleomycin. Biochem Biophys Res Commun 1993; 194: 333-7.
23. Spugnini EP, Porrello A,. Potentiation of chemotherapy in companion animals with spontaneous large neoplasms by application of biphasic electric pulses. J Exp Clin Cancer Res 2003; 22: 571-80.
24. Mir LM, Banoun H, Paoletti C,. Introduction of definite amounts of nonpermeant molecules into living cells after electropermeabilization: direct access to the cytosol. Exp Cell Res 1988; 175: 15-25.
25. Heller R, Jaroszeski M, Perrott R, Messina J, et al. Effective treatment of B16 melanoma by direct delivery of bleomycin using electrochemotherapy. Melanoma Res 1997; 7: 10-8.
26. Sadadcharam M, Soden DM, O'Sullivan GC,. Electrochemotherapy: an emerging cancer treatment. Int J Hyperthermia 2008; 24: 263-73.
27. Deroose JP, Eggermont AM, van Geel AN, Verhoef C,. Isolated limb perfusion for melanoma in-transit metastases: developments in recent years and the role of tumor necrosis factor alpha. Curr Opin Oncol 2011; 23: 183-8.
28. Rounsaville MC, Cantril ST, Fontanesi J, Vaeth JM, et al. Radiotherapy in the management of cutaneous melanoma: effect of time, dose, and fractionation. Front Radiat Ther Oncol 1988; 22: 62-78.
29. Green DS, Bodman-Smith MD, Dalgleish AG, Fischer MD,. Phase I/II study of topical imiquimod and intralesional interleukin-2 in the treatment of accessible metastases in malignant melanoma. Br J Dermatol 2007; 156: 337-45.
30. Schlaak M, Schmidt P, Bangard C, Kurschat P, et al. Regression of metastatic melanoma in a patient by antibody targeting of cancer stem cells. Oncotarget 2012; 3: 22-30.
31. Nordin P, Zetterström H, Carlsson P, Nilsson E,. Cost-effectiveness analysis of local, regional and general anaesthesia for inguinal hernia repair using data from a randomized clinical trial. Br J Surg 2007; 94: 500-5.
32. Rodríguez-Cuevas S, Barroso-Bravo S, Almanza-Estrada J, Cristõbal-Martínez L, et al. Electrochemotherapy in primary and metastatic skin tumors: phase II trial using intralesional bleomycin. Arch Med Res 2001; 32: 273-6.